Kistefos Venture Capital

Kistefos Venture Capital is a venture capital investment firm that invests in Norwegian and foreign companies within the offshore, shipping, financial services, telecommunications, real estate and financial sectors. Founded 1997 in Oslo, Norway by Christen Sveaas, this company invests in early stage ventures. Its portfolio companies include AntlerAntler, Semine, TradeIX, Line2, Kappa Bioscience, Bambuser, Promon, and OstomyCure. As of February 2020, Kistefos Venture Capital has made 8 investments. Their most recent investment was on Jan 7, 2020, when Antler raised $50M. Kistefos invests between NOK 10m and NOK +100m in each company.

Kistefos Venture Capital is a venture capital investment firm that invests in Norwegian and foreign companies within the offshore, shipping, financial services, telecommunications, real estate and financial sectors. Founded 1997 in Oslo, Norway by Christen Sveaas, this company invests in early stage ventures. Its portfolio companies include Antler, Semine, TradeIX, Line2, Kappa Bioscience, BambuserBambuser, Promon, and OstomyCure. As of February 2020, Kistefos Venture Capital has made 8 investments. Their most recent investment was on Jan 7, 2020, when Antler raised $50M. Kistefos invests between NOK 10m and NOK +100m in each company.

Kistefos Venture Capital is a venture capital investment firm that invests in Norwegian and foreign companies within the offshore, shipping, financial services, telecommunications, real estate and financial sectors. Founded 1997 in Oslo, Norway by Christen Sveaas, this company invests in early stage ventures. Its portfolio companies include Antler, Semine, TradeIXTradeIX, Line2, Kappa Bioscience, Bambuser, Promon, and OstomyCure. As of February 2020, Kistefos Venture Capital has made 8 investments. Their most recent investment was on Jan 7, 2020, when Antler raised $50M. Kistefos invests between NOK 10m and NOK +100m in each company.

Kistefos Venture Capital is the venture capital subsidiary of The Kistefos Group. It is headquartered in Oslo, Norway. The firm was founded by Christen Sveaas in 1997. Kistefos Venture Capital prefers to fund companies developing products and services in fields that The Kistefos Group have operations in, such as offshore, shipping, financial services, telecommunications, and real estate. Since its founding year, Kistefos Venture Capital has funded seven companies, with its most recent occurring in August 2018 for Semine.

Kistefos Venture Capital is a venture capital investment firm that invests in Norwegian and foreign companies within the offshore, shipping, financial services, telecommunications, real estate and financial sectors. Founded 1997 in Oslo, Norway by Christen Sveaas, this company invests in early stage ventures. Its portfolio companies include Antler, Semine, TradeIX, Line2, Kappa Bioscience, Bambuser, Promon, and OstomyCure. As of February 2020, Kistefos Venture Capital has made 8 investments. Their most recent investment was on Jan 7, 2020, when Antler raised $50M. Kistefos invests between NOK 10m and NOK +100m in each company.

Kistefos Venture Capital is the venture capital subsidiary of The Kistefos Group. It is headquartered in Oslo, Norway. The firm was founded by Christen Sveaas in 1997. Kistefos Venture Capital prefers to fund companies developing products and services in fields that The Kistefos Group have operations in, such as offshore, shipping, financial services, telecommunications, and real estate. Since its founding year, Kistefos Venture Capital has funded seven companies, with its most recent occurring in August 2018 for Semine.

Kistefos Venture Capital is the venture capital subsidiary of The Kistefos Group. It is headquartered in OsloOslo, Norway. The firm was founded by Christen Sveaas in 1997. Kistefos Venture Capital prefers to fund companies developing products and services in fields that The Kistefos Group have operations in, such as offshore, shipping, financial services, telecommunications, and real estate. Since its founding year, Kistefos Venture Capital has funded seven companies, with its most recent occurring in August 2018 for Semine.

Kistefos Venture Capital is the venture capital subsidiary of The Kistefos Group. It is headquartered in Oslo, NorwayNorway. The firm was founded by Christen Sveaas in 1997. Kistefos Venture Capital prefers to fund companies developing products and services in fields that The Kistefos Group have operations in, such as offshore, shipping, financial services, telecommunications, and real estate. Since its founding year, Kistefos Venture Capital has funded seven companies, with its most recent occurring in August 2018 for Semine.

Kistefos Venture Capital is the venture capitalventure capital subsidiary of The Kistefos Group. It is headquartered in Oslo, Norway. The firm was founded by Christen Sveaas in 1997. Kistefos Venture Capital prefers to fund companies developing products and services in fields that The Kistefos Group have operations in, such as offshore, shipping, financial services, telecommunications, and real estate. Since its founding year, Kistefos Venture Capital has funded seven companies, with its most recent occurring in August 2018 for Semine.